Development and validation of prognostic model based on distribution and density of CD3+ and CD8+ infiltrating lymphocytes in breast cancer: A multicenter cohort study
The PII model can predict survival in breast cancer patients, which might provide a novel risk classification to guide further individualized treatment.
Authors
- Xuening Fei (ORCID: https://orcid.org/0000-0002-9443-5237)
- Kunwei Shen (ORCID: https://orcid.org/0000-0002-1961-8666)
- Yiwei Tong (ORCID: https://orcid.org/0000-0001-5131-9095)
- Zheng Wang (ORCID: https://orcid.org/0000-0001-9252-2129)
- Xu Zhang (ORCID: https://orcid.org/0000-0002-8007-2762)
- Juanying Zhu
- Yujie Tang
- Xiaosong Chen (ORCID: https://orcid.org/0000-0002-3286-0035)
- Weiqi Gao (ORCID: https://orcid.org/0000-0003-0154-9524)
- Zhian Li (ORCID: https://orcid.org/0009-0006-7956-4985)
- Xi Sun
Institutions
- Shanghai Jiao Tong University (CN)
- Ruijin Hospital (CN)
- Jiaxing University (CN)
- Shaoxing Second Hospital (CN)
- First Hospital of Jiaxing (CN)
Publication Details
- Journal
- The Breast
- Published
- 2025-10-25
- DOI
- https://doi.org/10.1016/j.breast.2025.104632
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Shanghai
- National Natural Science Foundation of China
- Shanghai Municipal Education Commission
- Science and Technology Commission of Shanghai Municipality